Markets › United States › NAS › PMCB

PharmaCyte Biotech Inc

NAS:PMCBHealthcarenasdaq_composite

$0.3704+8.29%LiveIn session · ≈ AED 1.36 · Market cap $3.98M · Next earnings Wed 16 Dec

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Return on equity	−53.2%	−4.7%	−5.9%	0.8%	59.1%	−56.2%	−0.0%	+56.2 pts
Return on assets	−48.0%	−4.7%	−5.9%	0.6%	55.6%	−41.5%	−41.5%	+0.0 pts
Return on capital employed	−54.2%	−4.9%	−8.9%	−12.4%	−8.4%	−11.5%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	−1,189.4×	−8,628.7×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	3.1×	121.4×	116.2×	6.8×	7.7×	45.3×	45.3×	+0.0%
Quick ratio	3.1×	121.4×	116.2×	6.8×	7.7×	45.3×	—	—
Cash ratio	3.0×	121.2×	116.0×	6.8×	5.2×	22.5×	22.5×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	—	—	—	—	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	3.7%	−1.3%	—	—